C.J. Haagsma

3.7k citations

38 papers · 2.8k indexed · 1 hit paper · h-index 20

Impact in

Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 1%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 33
- Rheumatoid Arthritis Research and Therapies 27
- Systemic Lupus Erythematosus Research 13
Hematology 7
- Autoimmune and Inflammatory Disorders Research 6

Co-authors: Piet L. C. M. van Riel Anke M. van Gestel J.W.M. van der Meer Joost P.H. Drenth Monique Hoekstra Mart A F J van de Laar Henk J. Blom L B van de Putte
Journals: Lara D. Veeken (9 papers)Annals of the Rheumatic Diseases (3 papers)Arthritis Research & Therapy (3 papers)Medicine (1 paper)Annals of Medicine (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

C.J. Haagsma

37 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Validation of rheumatoid arthritis improvement criteria that include simplified joint counts 1998 · 635 citations

Peers

Countries citing papers authored by C.J. Haagsma

Since Specialization

Citations

This map shows the geographic impact of C.J. Haagsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Haagsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Haagsma more than expected).

Fields of papers citing papers by C.J. Haagsma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J. Haagsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Haagsma. The network helps show where C.J. Haagsma may publish in the future.

Co-authors

The 25 scholars most cited alongside C.J. Haagsma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C.J. Haagsma Line = papers co-authored together C.J. Haagsma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors Lara D. Veeken ·F. Lamers-Karnebeek, Jolanda J. Luime, David F Ten Cate, Steven Teerenstra, Nanno Swen, Andreas Gerards, Jos Hendrikx, Emma M. van Rooyen, R.E. Voorneman, C.J. Haagsma, N. Basoski, M. de Jager, Marjan Ghiti Moghadam, M. Efdé, Yvonne P M Goekoop-Ruiterman, Piet L. C. M. van Riel, Johannes W G Jacobs, Tim Jansen	2017	15
2	Development of a web-based patient decision aid for initiating disease modifying anti-rheumatic drugs using user-centred design methods BMC Medical Informatics and Decision Making ·Ingrid Nota, Constance H.C. Drossaert, Heleen C. Melissant, Erik Taal, Harald E. Vonkeman, C.J. Haagsma, Mart A F J van de Laar	2017	18
3	Comparison of 2 Dosages of Intraarticular Triamcinolone for the Treatment of Knee Arthritis: Results of a 12-week Randomized Controlled Clinical Trial The Journal of Rheumatology ·Jan Willem Popma, Frank W. Snel, C.J. Haagsma, Petra Brummelhuis-Visser, Hans G.J. Oldenhof, Job van der Palen, Mart A F J van de Laar	2015	23
4	Black and white: alkaptonuria and gout Lara D. Veeken ·Dennis Boumans, C.J. Haagsma	2013	1
5	A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry Annals of the Rheumatic Diseases ·L.G. Schipper, Marloes Vermeer, H. H. Kuper, Monique Hoekstra, C.J. Haagsma, Alfons A den Broeder, Piet L. C. M. van Riel, Jaap Fransen, Mart AFJ van de Laar	2011	127
6	Implementation of a treat-to-target strategy in very early rheumatoid arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study Arthritis & Rheumatism ·Marloes Vermeer, H. H. Kuper, Monique Hoekstra, C.J. Haagsma, Marcel D. Posthumus, Herman L. M. Brus, Piet L. C. M. van Riel, Mart A F J van de Laar	2011	105
7	A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout Annals of the Rheumatic Diseases ·M.K. Reinders, C.J. Haagsma, Tim Jansen, Eric N. van Roon, J Delsing, Mart A F J van de Laar, J. R. B. J. Brouwers	2008	141
8	Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis. PubMed ·Monique Hoekstra, C.J. Haagsma, Cees Neef, Johannes H. Proost, Antonius Knuif, Mart A F J van de Laar	2006	51
9	Corticosteroid injections reduce size of rheumatoid nodules Clinical Rheumatology ·H. Baan, C.J. Haagsma, Mart A F J van de Laar	2005	16
10	Homocysteine and folate status in methotrexate‐treated patients with rheumatoid arthritis Lara D. Veeken ·Annelies E. van Ede, Roland Laan, Henk J. Blom, G. H. J. Boers, C.J. Haagsma, Chris M.G. Thomas, Theo M. de Boo, L. B. A. van de Putte	2002	142
11	The C677T mutation in the methylenetetrahydrofolate reductase gene: A genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients Arthritis & Rheumatism ·Annelies E. van Ede, Roland Laan, Henk J. Blom, T. Huizinga, C.J. Haagsma, B. Giesendorf, Theo M. de Boo, Leo B. A. Van De Putte	2001	161
12	ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. PubMed ·Anke M. van Gestel, Jennifer J. Anderson, Piet L. C. M. van Riel, Maarten Boers, C.J. Haagsma, Benjamin Rich, George A. Wells, M. Lange, David T. Felson	1999	213
13	Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis Best Practice & Research Clinical Rheumatology ·Piet L. C. M. van Riel, C.J. Haagsma, Daniel E. Fürst	1999	6
14	Validation of rheumatoid arthritis improvement criteria that include simplified joint counts Arthritis & Rheumatism ·Anke M. van Gestel, C.J. Haagsma, Piet L. C. M. van Riel Hit paper breakdown →	1998	635
15	4 Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs) Baillière s Clinical Rheumatology ·Anke M. van Gestel, C.J. Haagsma, Daniel E. Fürst, Piet L. C. M. van Riel	1997	14
16	Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial Lara D. Veeken ·C.J. Haagsma, P L van Riel, Anja J. de Jong, L B van de Putte	1997	174
17	Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response British Journal of Clinical Pharmacology ·C.J. Haagsma, Frans G. M. Rüssel, Tom B. Vree, Piet L. C. M. van Riel, Levinus B. A. van de Putte	1996	23
18	EFFECT OF METHOTREXATE ALONE OR IN COMBINATION WITH SULPHASALAZINE ON THE PRODUCTION AND CIRCULATING CONCENTRATIONS OF CYTOKINES AND THEIR ANTAGONISTS. LONGITUDINAL EVALUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS Lara D. Veeken ·Pilar Barrera, C.J. Haagsma, A M Boerbooms, Piet L. C. M. van Riel, George F. Borm, L.B.A. van de Putte, J.W.M. van der Meer	1995	66
19	Combining Sulphasalazine and Methotrexate in Rheumatoid Arthritis: Early Clinical Impressions Lara D. Veeken ·C.J. Haagsma, P. L. C. M. van Riel, L. B. A. van de Putte	1995	4
20	ORAL STEROIDS AS BRIDGE THERAPY IN RHEUMATOID ARTHRITIS PATIENTS STARTING WITH PARENTERAL GOLD. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL Lara D. Veeken ·Anke M. van Gestel, Roland Laan, C.J. Haagsma, L B van de Putte, P.L. van Riel	1995	66

About C.J. Haagsma

C.J. Haagsma is a scholar working on Rheumatology, Hematology, Genetics, Pathology and Forensic Medicine and Immunology, having authored 38 papers that have together received 2.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (27 papers), Systemic Lupus Erythematosus Research (13 papers), Chronic Lymphocytic Leukemia Research (6 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Rheumatology (2.0k citations), Hematology (855 citations), Genetics (445 citations), Nephrology (197 citations) and Immunology (479 citations). C.J. Haagsma has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Piet L. C. M. van Riel, Anke M. van Gestel, J.W.M. van der Meer, Joost P.H. Drenth, Monique Hoekstra, Mart A F J van de Laar, Henk J. Blom, L B van de Putte, Roland Laan and Anja J. de Jong. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Arthritis Research & Therapy, Medicine and Annals of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact